Skip to main content

FDA Approvals

FDA Approvals
First-in-Class Angiotensin Receptor Neprilysin Inhibitor Promising in Heart Failure with Preserved Ejection Fraction
Mary Mosley
Read More
FDA Approvals
RELAX-AHF: Serelaxin Reduces Dyspnea in Acute Heart Failure
Mary Mosley
Read More
FDA Approvals
GLP-1 Agonism Holds Promise for Preventing Macrovascular Disease in Type 2 Diabetes
Wayne Kuznar
Read More
FDA Approvals
CVD Pipeline: Novel Approaches to Modifying Lipids/Lipoproteins
Mary Mosley
Read More
FDA Approvals
Payer Drug and Molecular Testing Utilization Policies
Charles Bankhead, Medical Writer
Read More
FDA Approvals
Empagliflozin Safe and Effective with or without Metformin, Reduces Weight
Mary Mosley
Read More
FDA Approvals
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Mary Mosley
Read More
FDA Approvals
New Long-Acting Insulin Degludec Lowers Hypoglycemia Significantly versus Insulin Glargine
Wayne Kuznar
Read More
FDA Approvals
The Ancient Anti-Inflammatory Drug Salsalate Lowers Blood Glucose Levels
Wayne Kuznar
Read More
FDA Approvals
Diabetes Drug Pipeline: Promising Agents in Late Stages of Development
Wayne Kuznar
Read More
Page 50 of 53
Results 491 - 500 of 525